Document is current
Any future updates will be listed below
-
Authors
,
Di Blasi, Roberta https://orcid.org/0000-0001-9001-573X
Cattaneo, Chiara
Lewis, Russell E.
Tumbarello, Mario
Angelici, Laura
Dragonetti, Giulia
Busca, Alessandro
Cambò, Benedetta
Candoni, Anna
Cesarini, Monica
Cesaro, Simone
Delia, Mario
Fanci, Rosa
Farina, Francesca
Garzia, Mariagrazia
Giordano, Antonio
Martino, Bruno
Melillo, Lorella
Nadali, Gianpaolo
Perriello, Vincenzo
Picardi, Marco
Quinto, Angela Maria
Salutari, Prassede
Spolzino, Angelica
Vacca, Adriana
Vetro, Calogero
Zancanella, Michelle
Nosari, Annamaria
Aversa, Franco
Pagano, Livio
- License Information
-
More Information
Article History
Received: 25 February 2017
Accepted: 21 January 2018
First Online: 7 February 2018
Compliance with ethical standards
: The study was approved by the ethics committee of each center.
: R.D.B. has received honoraria from Gilead Sciences and Merck. C.C. has no disclosures. R.E.L. has received honoraria from Gilead Sciences and Astellas Pharma and has research grants from Gilead Sciences. A.B. has received honoraria from Gilead Sciences, Merck, Pfizer Pharmaceuticals, Basilea, Jazz Pharmaceuticals and Hospira; he has been a speaker for Gilead Sciences, Merck, Pfizer Pharmaceuticals, Astellas Pharma, and Novartis. A.C. has received honoraria from Gilead Sciences, Merck and Pfizer Pharmaceuticals and has been a speaker for Gilead Sciences, Merck, and Pfizer. S.C. has received speaker honoraria from Gilead Sciences and Merck Sharp and Dohme. M.D. has been the consultant/speaker for Gilead Sciences, Merck, Pfizer, Sanofi. R.F. has received honoraria from Merck and has been a speaker for Merck. G.N. has been a speaker for Pfizer and Merck. A.N. has received honoraria from Gilead Sciences and speaker honoraria from Merck. F.A. has received honoraria from Gilead Sciences, Basilea, Merck, Roche and Pfizer Pharmaceuticals and has been a speaker for Gilead Sciences, Merck, Pfizer and Roche. L.P. has received honoraria from Gilead Sciences, Jannsen, Basilea, Merck and Pfizer Pharmaceuticals and has been a speaker for Gilead Sciences, Merck, and Basilea. All other authors declare no conflict of interest.
